A specific regulatory protein significantly influences the development of tumor-inducing blood vessels in the bone marrow of blood cancer patients. Using a series of different
Read more
Home ยป
Car T-cell therapy, described as a “living drug,” is now available for patients with relapsed/refractory multiple myeloma who have been treated with four or more
Read more